Dr. James Gulley is a renowned oncologist and immunotherapy researcher who has contributed significantly to cancer vaccines development and immunotherapies. He has been involved in clinical trials and research related to cancer vaccines, particularly in the context of prostate cancer and other malignancies. As a leading figure at the National Cancer Institute (NCI), he has played a vital role in advancing cancer immunotherapy approaches.